Short- and Long-Term Outcomes of Infliximab Treatment for Steroid-Refractory Ulcerative Colitis and Related Prognostic Factors: A Single-Center Retrospective Study

By  

Digestion, Vol. 95, Iss. 1, 2017-01 ,pp. : 67-71

Karger

Access to resources Recommend Favorite

Rapid endoscopic improvement is important for 1-year avoidance of colectomy but not for the long-term prognosis in cyclosporine A treatment for ulcerative colitis

By Kobayashi Taku   Naganuma Makoto   Okamoto Susumu   Hisamatsu Tadakazu   Inoue Nagamu   Ichikawa Hitoshi   Takayama Tetsuro   Saito Riko   Sujino Tomohisa   Ogata Haruhiko   Iwao Yasushi   Hibi Toshifumi  

Journal of Gastroenterology, Vol. 45, Iss. 11, 2010-11 ,pp. : 1129-1137

Springer Publishing Company

Access to resources Recommend Favorite

Low remission rates but long drug survival in rheumatoid arthritis patients treated with infliximab or etanercept: results from the nationwide Danish DANBIO database

By Østergaard M.   Unkerskov J.   Linde L.   Krogh N. S.   Ravn T.   Ringsdal V. S.   Petri A.   Andersen L. S.   Tarp U.   Hansen A.   Hjardem E.   Hetland M. L.  

Scandinavian Journal of Rheumatology, Vol. 36, Iss. 2, 2007-01 ,pp. : 151-154

Informa Healthcare

Access to resources Recommend Favorite

Long-term outcome of infliximab therapy is highly comparable in a Danish and in a Hungarian tertiary center

By Molnáár Tamáás   Farkas Klaudia   Szepes Zoltáán   Nagy Ferenc   Wittmann Tibor  

Scandinavian Journal of Gastroenterology, Vol. 46, Iss. 2, 2011-02 ,pp. : 248-249

Informa Healthcare

Access to resources Recommend Favorite

Clinical experience with infliximab and adalimumab in a single-center cohort of patients with Crohn's disease

By Riis Åse   Martinsen Tom C.   Waldum Helge L.   Fossmark Reidar  

Scandinavian Journal of Gastroenterology, Vol. 47, Iss. 6, 2012-06 ,pp. : 649-657

Informa Healthcare

Access to resources Recommend Favorite